-
Innovation Ranking
NewInnovation Ranking – Pharmaron Beijing Co Ltd
Pharmaron Beijing Co Ltd (Pharmaron) is a life science service company that provides drug research and development services in the areas of chemistry, biology, pharmacology, DMPK, toxicology and chemical development. The company's service offerings include synthetic, medicinal and analytical chemistry, biology, pharmacology, drug safety assessment, radiochemistry and isotopically labeled metabolism, chemical and pharmaceutical development and clinical development services. Pharmaron serves small and large biotechnology and pharmaceutical companies. The company operates chemical manufacturing, drug R&D, radiolabelled chemistry and metabolism and clinical...
-
Company Insights
Innovation and Patenting activity of Pharmaron Beijing Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Pharmaron Beijing Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
Pharmaron Beijing – Life Sciences Research and Development Center – Liverpool
Equip yourself with the essential tools needed to make informed and profitable decisions with our Pharmaron Beijing - Life Sciences Research and Development Center - Liverpool report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Company Profile
Pharmaron Beijing Co Ltd – Company Profile
Pharmaron Beijing Co Ltd (Pharmaron) is a life science service company that provides drug research and development services in the areas of chemistry, biology, pharmacology, DMPK, toxicology and chemical development. The company's service offerings include synthetic, medicinal and analytical chemistry, biology, pharmacology, drug safety assessment, radiochemistry and isotopically labeled metabolism, chemical and pharmaceutical development and clinical development services. Pharmaron serves small and large biotechnology and pharmaceutical companies. The company operates chemical manufacturing, drug R&D, radiolabelled chemistry and metabolism and clinical...
Add to Basket -
Sector Analysis
Contract Small Molecule API Manufacturing Industry by the Numbers – 2021 Edition
According to the Global Data’s Drugs database, it indicates that maximum of the marketed drugs is found to be small molecules, despite many of the prominent contract manufacturing organizations (CMOs) investing in advanced therapy medicinal product (ATMP) capabilities in recent years and an increasing use of biologic APIs in both the pipeline and among marketed drugs. With the increase in high potency small molecule APIs, has been driven by the rise of oncology pipeline drugs coupled with small or virtual...
-
Sector Analysis
United States (USA) Orthopedic Devices Market Size (Value, Volume, ASP) by Segments (Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction and Others), Share and Forecast, 2015-2025
GlobalData’s “United States Orthopedic Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Orthopedic Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools and Consumables, Other Joint Reconstruction, Shoulder Replacement, Spinal Surgery and Trauma Fixation. The United States Orthopedic Devices Market report provides...
-
Track & Monitor
PharmSource – M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition
This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
-
Track & Monitor
Contract Small Molecule API Manufacturing Industry by the Numbers – 2019 PharmSource Edition
This report characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.